Viatris Announces Third Quarter 2024 Dividend

VTRS 11.05.2024

Full Press ReleaseSEC FilingsOur VTRS Tweets

About Gravity Analytica

Recent News

  • 01.14.2025 - JPMorgan 43rd Annual Healthcare Conference
  • 01.07.2025 - Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference
  • 12.23.2024 - Viatris Statement Regarding Receipt of Warning Letter and Import Alert for Indore, India Facility

Recent Filings

  • 01.03.2025 - 4 Statement of changes in beneficial ownership of securities
  • 12.06.2024 - 8-K Current report

PITTSBURGH,Nov. 5, 2024/PRNewswire/ --Viatris Inc. (NASDAQ: VTRS) today announced that onNovember 4, 2024, its Board of Directors declared a quarterly dividend of$0.12per share for each issued and outstanding share of the Company's common stock. The dividend is payable onDecember 13, 2024, to shareholders of record as of the close of business onNovember 22, 2024.

AboutViatris

Viatris Inc.(NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning atViatris. We are headquartered in theU.S., with global centers inPittsburgh,Shanghaiand Hyderabad,India. Learn more atviatris.comandinvestor.viatris.com, and connect with us onLinkedIn,Instagram,YouTubeandX(formerly Twitter).

Forward-Looking Statements

This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward looking statements may include statements thatViatris'Board of Directors declared a quarterly dividend of$0.12per share for each issued and outstanding share of the Company's common stock payable onDecember 13, 2024, to shareholders of record as of the close of business onNovember 22, 2024. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in theU.S.and abroad; any regulatory, legal or other impediments toViatris'ability to bring new products to market, including but not limited to "at-risk" launches;Viatris'or its partners' ability to develop, manufacture, and commercialize products; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings; the possibility thatViatrismay be unable to realize the intended benefits of, or achieve the intended goals or outlooks with respect to, its strategic initiatives; the possibility thatViatrismay be unable to achieve intended or expected benefits, goals, outlooks, synergies, growth opportunities and operating efficiencies in connection with divestitures, acquisitions, other transactions or restructuring programs, within the expected timeframes or at all; goodwill or impairment charges or other losses related to the divestiture or sale of businesses or assets;Viatris'failure to achieve expected or targeted future financial and operating performance and results; the potential impact of public health outbreaks, epidemics and pandemics; any significant breach of data security or data privacy or disruptions to our information technology systems; risks associated with international operations; the ability to protect intellectual property and preserve intellectual property rights; changes in third-party relationships; the effect of any changes inViatris'or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions ofViatrisor its partners; uncertainties and matters beyond the control of management, including general economic conditions, inflation and exchange rates; failure to execute stock repurchases consistent with current expectations; stock price volatility; and the other risks described inViatris'filings with theSecurities and Exchange Commission(SEC).Viatrisroutinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of theSEC'sRegulation Fair Disclosure (Reg FD).Viatrisundertakes no obligation to update these statements for revisions or changes after the date of this press release other than as required by law.

# # #

Viatris OUS Logo (PRNewsfoto/Viatris Inc.)

CisionView original content to download multimedia:https://www.prnewswire.com/news-releases/viatris-announces-third-quarter-2024-dividend-302296180.html

SOURCEViatris Inc.

Contacts: MEDIA: +1.724.514.1968, Communications@viatris.com; Jennifer Mauer, Jennifer.Mauer@viatris.com; Matt Klein, Matthew.Klein@viatris.com; INVESTORS: Bill Szablewski, +1.412.707.2866, InvestorRelations@viatris.com, William.Szablewski@viatris.com; Jill Sawyer, Jill.Sawyer@viatris.com

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com